American Association for Cancer Research

The Science Behind Tobacco Control

On June 22, 2009, Congress granted the U.S. Food and Drug Administration unprecedented authority to regulate the marketing, advertising and manufacturing of tobacco products. In the past three years, the agency has made significant strides to protect the public from tobacco, including imposing a ban on flavored cigarettes and introducing bold new health warning labels for cigarette packages and advertisements.

Fully combating the tobacco epidemic, however, will be a long-term struggle, as emphasized by a panel of experts who spoke June 12, 2012, during an AACR-sponsored Capitol Hill briefing. More federal funding and further research will be needed to guide regulatory and clinical approaches and to evaluate the impact of new policies.

The briefing highlighted the evidence that underpins successful interventions in both preventing the initiation of tobacco use and helping those who are addicted to quit. Panelists updated congressional aides and health advocates in attendance about the latest understanding of the many ways that tobacco use adversely affects health, especially in cancer patients, and profiled evidence that showed significantly improved survival and outcomes for cancer patients who quit smoking after diagnosis when compared with those who continued to smoke during their treatment.

 

Panelists:

  • Dr. Roy Herbst, Yale Comprehensive Cancer Center (Bio) (Slide Presentation*)
  • Dr. Lawrence Deyton, FDA Center for Tobacco Products (Bio)
  • Dr. Ellen R. Gritz, MD Anderson Cancer Center (Bio) (Slide Presentation*)
  • Gruen Von Behrens, oral cancer survivor and nationally-known motivational speaker (Bio)

*Please request permission to use slides

 

Related Documents:

 

 

Panel_Tobacco2012

(LtoR) Dr. Roy Herbst, Yale Comprehensive Cancer Center; Dr. Lawrence Deyton, FDA Center for Tobacco Products; Sen. Richard Blumenthal (D-Conn.); Dr. Ellen R. Gritz, MD Anderson Cancer Center; Gruen Von Behrens, oral cancer survivor and nationally-known motivational speaker

 

Herbst_Blumenthal

Dr. Roy Herbst greets Sen. Richard Blumenthal, a staunch tobacco control advocate

 

Deyton

Dr. Lawrence Deyton, director of the FDA Center for Tobacco Products, details the implementation of the 2009 Family Smoking Prevention and Tobacco Control Act, which for the first time gave the FDA authority to regulate tobacco products, and also put in place a number of requirements that rely on scientific evidence.

 

Gruen_2012

Gruen Von Behrens shares his story of contracting oral cancer at the age of 17 after using smokeless tobacco beginning at the age of 13.

 

EllenGritz

Dr. Ellen R. Gritz profiles evidence showing significantly improved survival and outcomes for cancer patients who quit smoking after diagnosis when compared with those who continued to smoke during their treatment.